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Abstract
Background: The cardiovascular impact of cocaine use in otherwise healthy individuals who consider themselves ‘social’
users is not well established.
Methods/Results: Twenty regular cocaine users and 20 control subjects were recruited by word-of-mouth. Cardiovascular
magnetic resonance was performed to assess cardiac and vascular structure and function. Cocaine users had higher systolic
blood pressure compared to non-users (134611 vs 126611 mmHg, p = 0.036), a finding independent of age, body surface
area, smoking and alcohol consumption. Cocaine use was associated with increased arterial stiffness - reflected by reduced
aortic compliance (1.360.2 vs 1.760.5 cm261022.mmHg21, p = 0.004), decreased distensibility (3.860.9 vs
5.161.4 mmHg21.1023, p = 0.001), increased stiffness index (2.660.6 vs 2.160.6, p = 0.005), and higher pulse wave velocity
(5.160.6 vs 4.460.6 m.s21, p = 0.001). This change in aortic stiffness was independent of vessel wall thickness. Left
ventricular mass was 18% higher in cocaine users (124625 vs 105616 g, p = 0.01), a finding that was independent of body
surface area, and left atrial diameter was larger in the user group than controls (3.860.6 vs 3.560.3 cm, p = 0.04). The
increased left ventricular mass, systolic blood pressure and vascular stiffness measures were all associated with duration
and/or frequency of cocaine use. No late gadolinium enhancement or segmental wall motion abnormalities were seen in
any of the subjects.
Conclusions: Compared with the non-user control cohort, cocaine users had increased aortic stiffness and systolic blood
pressure, associated with greater left ventricular mass. These measures are all well known risk factors for premature
cardiovascular events, highlighting the dangers of cocaine use, even in a ‘social’ setting, and have important public health
implications.
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Introduction
Cocaine is an illicit drug that is frequently used across a wide
range of demographic groups. The acute cardiovascular effects of
cocaine are well known and include, but are not limited to:
accelerated hypertension [1], acute myocardial ischaemia and
infarction [2], aortic dissection [3], and life-threatening arrhyth-
mias [4]. These acute effects are attributed to a number of
mechanisms including cocaine’s powerful sympathomimetic prop-
erties [5], coronary artery vasoconstriction by direct vessel smooth
muscle activation [6], the inhibition of endogenous nitric oxide
production and the release of potent vasoconstrictors such as
endothelin-1 [7]. Cocaine also has an acute effect on arterial
thrombosis through a number of mechanisms acting on platelets
[8,9].
The chronic effects of cocaine use are difficult to study, and data
is mostly derived from small cohorts of cocaine ‘addicts’ or
‘abusers’ recruited from drug rehabilitation centres that may not
represent the average user. In the ‘addict’ population, cocaine use
has been associated with myocardial fibrosis [10,11], impairment
in both systolic and diastolic function [12] and left ventricular
hypertrophy [13,14]. However, the chronic effect of regular
cocaine use in otherwise healthy adults who consider themselves as
‘social’ users is more difficult to establish. According to the
Australian 2010 National Drug Strategy Household Survey report
[15], 7.8% of Australians aged 18+ had used cocaine in their
lifetime, and 2.1% in the last 12 months. Also, users were
predominantly male, aged 20–39 years, currently employed with
post-school qualifications, living in major cities, and of the highest
socioeconomic status [15]. In Australia, studies examining cocaine
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users across the Sydney metropolitan area have identified two
distinct groups of users – a group with a higher socio-economic
status (SES) and a group with a lower SES [16–18]. The lower
SES group had lower levels of education, higher unemployment,
were more criminally active, and had higher levels of cocaine use
and diagnosis of cocaine dependence. These users preferred
injecting as the means of cocaine administration, and more
frequently used cocaine in combination with heroin. The higher
SES users had regular or above average incomes and reported
quite a different usage profile - typically taking cocaine intra-
nasally, usually in conjunction with alcohol, on a recreational
basis, considering themselves ‘social’ users rather than ‘addicts’.
Cardiovascular Magnetic Resonance Imaging (CMR) is a non-
invasive imaging modality with the ability to characterize
myocardium, as well as to accurately measure cardiac and
vascular function [19]. A specific advantage of CMR that is
especially relevant to this study is the ability to detect focal fibrosis
and silent myocardial infarction (MI) through the use of late
gadolinium enhancement (LGE) [20]. Furthermore, CMR can
provide a rapid and comprehensive assessment of aortic vascular
health through parameters such as compliance, distensibility,
stiffness index, and pulse wave velocity [21]. We hypothesise that
significant cardiovascular abnormalities are present in asymptom-
atic regular cocaine users, and that these will be detectable using
CMR.
Methods
Ethics Statement
The study was approved by the authors’ local institutional ethics
committee (Northern Sydney Local Health District Human
Research Ethics Committee). Informed written consent was
obtained from all study participants. All clinical investigation
was conducted according to the principles expressed in the
Declaration of Helsinki.
Sample Population
Twenty subjects with self-reported regular cocaine use (‘users’),
and 20 control subjects (‘non-users’) were enrolled. The inclusion
criteria were regular frequent cocaine use (defined as at least
monthly during the last year) for users and no prior cocaine use for
non-users. Exclusion criteria for both groups were known coronary
disease or previous MI (self-reported), a contraindication to CMR,
or self-reported cocaine use in the 48 hours prior to image
acquisition. All participants were over 18 years of age and
employed. Recruitment was by ‘word-of-mouth’, and predomi-
nantly depended on professional and social networks in an affluent
region of Sydney, Australia. Specifically, in contrast to previous
studies, we avoided recruitment through drug rehabilitation
centres, minimising the number of individuals with a clinical
psychiatric diagnosis of cocaine addiction or dependence. All
participants completed a questionnaire designed by investigators
(SK, SD) at the National Drug and Alcohol Research Centre
detailing their demographics, substance use history (including
tobacco and alcohol), and cardiac risk factors. Subjects remained
anonymous, and personal, demographic, recruitment, and CMR
data were all kept strictly confidential.
Cardiovascular magnetic resonance imaging
All magnetic resonance (MR) data was acquired at a single site
using a 1.5 Tesla MR system (GE Healthcare, Milwaukee,WI).
Cardiac chamber volumes and myocardial mass were quantified
using a short axis stack of Balanced Steady-State Free Precession
(bSSFP) cine images (Echo Time (TE) = 1.6 ms; 20 phases; flip
angle = 55u). Images were acquired during end-expiratory breath
hold. Left and right ventricular volumes, mass and ejection
fraction were obtained from the short axis stack by manually
contouring end-diastolic and end-systolic endocardial and epicar-
dial borders from the base to the apex. Parameters were indexed to
body surface area (BSA) using height and weight obtained from
patient questionnaires. Measurements reflecting diastolic function
were left ventricular peak filling rate (PFR), time to peak filling rate
(TPFR) [22] and left atrial (LA) diameter (measured in the 3-
chamber view at end-systole) [23]. Cine image analysis was
performed using ReportCard (GE Healthcare, Milwaukee,WI).
Aortic cine images were acquired in the transverse plane, with
location of the slice based on scout images (Figure 1A–B) at the
level of the right pulmonary artery/pulmonary arch in the
proximal descending aorta (PDA). Indices of aortic function were
assessed using a prospectively gated cine sequence with a temporal
resolution of 30-frames/heartbeat. Sequence parameters were:
Field of View (FOV)= 350 mm, TE=1.4 ms, matrix = 2006200,
slice thickness = 8 mm. Gradient echo flow-encoded cine images
were acquired with 30 phases and a slice thickness of 4 mm. Aortic
cross-sections were manually contoured using Osirix (Rosset,
2004) to calculate the maximal (systolic) and minimal (diastolic)
vessel cross-sectional areas. Using these measurements, aortic
indices of vascular function at the level of the PDA were calculated
using the formulas in Figure 1C [24,25]. Resting brachial arterial
blood pressure was recorded once, by an experienced medical
doctor, immediately prior to image acquisition using a manual
sphygmomanometer (cuff size 25–34 cm), with the participant in
the prone position with arm extended. Measurements of lumen
diameter and area, wall thickness, and normalised wall index
(NWI= (total vessel area-lumen area)/total vessel area)) [26] were
manually contoured using Osirix from high-resolution black blood
images taken at the level of the PDA. An average of 3 repeated
contour measurements was taken.
LGE imaging was performed 7–15 min after contrast admin-
istration (0.2 mmol/kg body weight of gadobenate dimeglumine
Figure 1. A–B. Scout cardiovascular magnetic resonance image of
thoracic aorta demonstrating the planning of a transverse section
through proximal descending aorta at the level of the right pulmonary
artery. C. Arterial stiffness equations. Area(s) = systolic area, area(-
d) = diastolic area, DP= SBP-DBP, r=blood density (1059 kg.m23).
doi:10.1371/journal.pone.0089710.g001
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(Multihance, Bracco Diagnostics, USA). The inversion time was
individually adapted to suppress the remote myocardium signal
(typical range from 180 to 210 ms). Sequence parameters were:
FOV=350 to 400 mm, Repetition time (TR)/TE=4.6/1.3 ms,
flip angle = 20u, matrix = 2566192, slice thickness = 8 mm. The
presence of LGE was assessed by two independent expert
observers.
Statistical Analysis
Statistical analysis was carried out using SPSS 19 (IBM, 2011).
All continuous variables are expressed as mean6standard
deviation. Categorical variables are expressed as frequencies or
as percentages. Normality was checked using the Shapiro-Wilk
test. Groups were compared using independent-samples t-test for
normally distributed continuous variables, the Mann-Whitney U
test for non-normally distributed variables, and using Chi-squared
test for binomial or ordinal variables. Our sample size of 20
cocaine users gives us an 88% power to detect a 10% increase in
LV mass index with an a-value of 5%. Univariate analyses were
initially performed in order to identify which factors were
associated with the chosen dependent variables: SBP (systolic
blood pressure), aortic stiffness indices and aortic dimensions,
LVM (left ventricular mass), LVEDV (left ventricular end-diastolic
volume), RVEDV (right ventricular end diastolic volume), LA
diameter, PFR, TPFR. Variables entered into the model included
cocaine use status (user or non-user), age, gender, BSA, smoking
pack years (number of years of smoking equivalent to 1 pack ( = 20
cigarettes) per day) and alcohol (number of standard drinks per
week – calculated from self-reported frequency of alcohol
consumption and number of standard drinks per session).
Backwards step-wise linear regression analyses were then per-
formed in order to identify the most important independent
associations of the dependent variables. The unstandardized
coefficient B and its 95% confidence interval were recorded. A
p-value of ,0.05 was considered statistically significant.
Results
Participant Characteristics
Table 1 summarises the demographics of both groups. All
participants completed the questionnaire and CMR imaging
protocol. Both groups were similar in age, gender distribution and
self-reported history of dyslipidaemia and diabetes mellitus. No
subjects reported taking regular cholesterol modifying drugs,
diabetic or anti-hypertensive medications. Cocaine users com-
pared to controls were observed to have a 7% higher BSA
(p = 0.03), were more likely to be current smokers (45% vs 5%,
p= 0.003), and had higher life-long smoking consumption,
although the reported amount was low in both groups (smoking
pack years 2.3665.20 vs 0.0160.06, p = 0.05). Cocaine users had
a similar pattern of frequency of alcohol consumption compared to
controls. However, they were more likely to consume a greater
number of standard drinks per session. Cocaine users also had a
higher self-reported usage of other illicit drugs in their lifetime
(95% vs 35%, p,0.001). Concomitant consumption of cocaine,
smoking, alcohol and other illicit drugs was not reported.
The median age of first cocaine use was 21 years (range 17–
50 yrs.), with the majority of subjects (70%) having used cocaine
for over 10 years. Sixty five per cent of cocaine users had a regular
pattern of use with a frequency of at least 1–2 days per week. The
remaining subjects had a more variable pattern of use, estimated at
least monthly over the preceding year. The route of administration
most commonly used was nasal insufflation (n= 16, 80%). The
other routes were smoking (n= 3, 15%) and injection (n= 1, 5%).
All participants had abstained from cocaine use for at least
48 hours prior to imaging (self-reported), satisfying the inclusion
criteria, with the average time period between last cocaine use and
imaging being 33 days in the user group.
Haemodynamic and vascular parameters
The haemodynamic and vascular parameters of participants are
summarised in Table 2. The results of the multivariate analyses are
presented in Table 3 and Table S1 in File S1. Cocaine users had a
significantly higher SBP (difference of mean 8 mmHg; p= 0.04),
and cocaine use was the most significant predictor of SBP entered
into the regression model (B = 7.6 mmHg (95% CI 0.5–14.7),
p = 0.036). The relationship between SBP and cocaine use was
independent of other covariates including age, gender, BSA,
smoking and alcohol consumption. There was a positive relation-
ship between SBP and frequency of cocaine use (B = 0.38 mmHg/
times used per week, 95%CI 0.3–7.2, p = 0.04); and a trend
towards a significant relationship between SBP and duration of
cocaine use (B= 0.5 mmHg/year, 95%CI20.2–1.0, p = 0.06). No
significant difference existed between the user group and controls
for diastolic blood pressure (DBP) or heart rate.
Cocaine users had a reduction in mean compliance and
distensibility in the PDA of 24% and 34% respectively with
reciprocal increases in stiffness index and pulse wave velocity
compared to non-users (Table 2). These differences remained
significant after including the covariates smoking, alcohol, age,
gender, and BSA in the model, and regression analyses indicated
cocaine use to be an independent predictor of distensibility and
compliance. The distribution of compliance measures in the two
groups is shown in a scatterplot in Figure S1 in File S1. There was
a positive relationship between compliance and both duration and
frequency of cocaine use (B =20.02 cm261022.mmHg21/year,
95%CI 20.04–20.01, p = 0.01; B=20.16 cm261022.mmHg21/
times used per week, 95%CI 20.28–20.04, p = 0.01, respective-
ly). Of note, the change in aortic stiffness observed in cocaine users
occurred without a concomitant increase in vessel wall thickness
(Table 2).
Ventricular structure, mass and function
CMR measures of cardiac mass and function parameters are
summarised in Table 4 and Table S2 in File S1. Cocaine users had
an 18% greater LVM (p= 0.01), a difference that remained
significant after indexing for BSA (p= 0.04). The distribution of
indexed LVM in the two groups is shown as a scatterplot in Figure
S2 in File S1. All increased LVMs were observed to be in a
concentric pattern. The association between cocaine use and
indexed LVM was independent of age, gender, smoking and
alcohol use. Regression analysis showed cocaine use as the
strongest predictor of indexed LVM (B= 7.71 g.m22 (95% CI
0.5–15.0), p = 0.038) (Table 5). Indexed LVM was positively
associated with frequency of cocaine use (B = 4.2 g.m22, 95%CI
0.6–7.7, p = 0.02). There was a trend towards a positive
association between indexed LVM and duration of cocaine use
(B = 0.4 g.m22, 95%CI 20.1–0.9, p = 0.09). All other measures of
ventricular volume and function were not significantly different
between the groups.
Considering the significant findings of elevated SBP and
increased LVM in the cocaine user group, we further examined
CMR indicators of diastolic function (Table S2 in File S1).
Increasing age, but not cocaine use, was a significant predictor of
PFR and TPFR. LA diameter was significantly greater in cocaine
users compared to non-users (3.860.6 cm vs. 3.560.3 cm,
p= 0.04), however the difference did not remain significant after
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indexing for BSA, and cocaine use was not a significant
contributor to LA diameter in regression analyses.
Myocardial Assessment
There was no evidence of silent MI as determined by
myocardial LGE in any of the study participants. There were
also no segmental wall motion abnormalities in either group.
Recruitment and analysis of matched control group
As this was the first study to attempt to examine the impact of
cocaine use in a non-institutionalized user group, the control
group was initially randomly recruited from the same community
group as the user group. As shown in Table 1, this resulted in
suboptimal matching of key covariates in the two groups. We
subsequently improved the matching by excluding 4 control
individuals who had no smoking or alcohol history, and recruiting
an additional 4 individuals who were known smokers, with
moderate alcohol consumption. As shown in Table S4 in File S1,
the matching of baseline characteristics was much improved by
this approach, with no significant differences in smoking, BSA,
age, or frequency of alcohol consumption. The key outcome
measures in the matched cohort are presented in Tables S5–6 in
File S1. SBP, indexed LVM and vascular stiffness (represented by
compliance in the PDA) remain significantly different between the
user and non-user groups, and cocaine remains an independent
predictor of these measures in regression analyses.
Table 1. Participant characteristics.
Non Users (n =20) Users (n =20) p value
Age (yrs) 3367 3767 0.07
Male gender 19 (95%) 17 (85%) 0.3
Body surface area (m2) 2.0960.2 1.9560.2 0.03
Diabetes 0 0 -
Dyslipidaemia history 0 (0%) 3 (15%) 0.07
Current smoker 1 (5%) 9 (45%) 0.003
Smoking pack years 0.0160.06 2.3665.20 0.05
Frequency of alcohol consumption 0.6
Never 2 (10%) 1 (5%)
Monthly or less 2 (10%) 1 (5%)
2–4 times per month 5 (25%) 4 (20%)
2–3 times per week 9 (45%) 8 (40%)
4+ times per week 2 (10%) 6 (30%)
Alcoholic drinks per session 0.03
1 or 2 9 (45%) 1 (5%)
3 or 4 7 (35%) 7 (35%)
5 or 6 4 (20%) 3 (15%)
7 or 9 0 (0%) 6 (30%)
10+ 0 (0%) 3 (15%)
Lifetime use of other drugs 7 (35%) 19 (95%) ,0.001
doi:10.1371/journal.pone.0089710.t001
Table 2. Haemodynamic and vascular parameters.
Non users Users p value
Systolic BP (mmHg) 126611 134611 0.04
Diastolic BP (mmHg) 83613 8569 0.63
Heart rate (beats/min) 6869 66610 0.47
Compliance (cm2.10-2 mmHg-1)* 1.760.5 1.360.2 0.03
Distensibility (10-3.mmHg-1)* 5.161.4 3.860.9 0.002
Stiffness Index 2.160.6 2.660.6 0.005
Pulse wave velocity (m.s-1) 4.460.6 5.160.6 0.001
Wall thickness (mm)* 2.360.3 2.460.3 0.8
Normalised Wall Index* 0.3460.38 0.3360.03 0.4
* indicates variables analysed by Mann-Whitney U test.
doi:10.1371/journal.pone.0089710.t002
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Discussion
This study demonstrates that significant cocaine-related cardio-
vascular abnormalities are present in otherwise healthy cocaine
users who were recruited by word-of-mouth in a well-off area of
Sydney, Australia. The key cocaine-associated changes were
increased arterial stiffness, elevated SBP and greater LVM in the
cocaine user group, findings that were independent of other
covariates, including smoking and alcohol consumption. We
observed no evidence of silent MI, nor left ventricular diastolic
or systolic dysfunction.
In contrast to other previous studies, and in accordance with
our aim to recruit healthy individuals who considered themselves
‘social’ users, we did not recruit our cocaine using subjects from
drug rehabilitation centres, nor did we require a clinical
psychiatric diagnosis of cocaine addiction for enrolment. Instead
we relied on ‘word-of-mouth’, which filtered along both social and
professional networks to enrol individuals who self-reported their
cocaine use. This resulted in our study population reflecting the
majority of cocaine users in Australia – young, and employed
people who generally snort cocaine on a recreational basis and are
considered socially and economically integrated – hence are very
relevant to the public health problems associated with cocaine use
in our community. This sub-group of users have previously been
observed to start using cocaine on a ‘‘social-recreational’’ basis;
and do ‘‘not expect to become dependent on a drug that is
Table 3. Statistical analyses of systolic blood pressure and vascular parameters.
Dependent
Variables
Variables in
Model Univariate B (95% CI) p value Multivariate B (95% CI) p value
SBP Cocaine use 7.6 mmHg (0.5, 14.7) 0.036 7.6 mmHg (0.5, 14.7) 0.036
Age - 0.13 -
Gender - 0.79 -
BSA - 0.25 -
Smoking - 0.5 -
Alcohol - 0.27 -
Compliance Cocaine use 20.37 cm2.10-2.mmHg-1 (20.61,20.13) 0.004 20.37 cm2.10-2.nnHg-1 (20.61,20.13) 0.004
Age - 0.08 -
Gender - 0.85 -
BSA - 0.15 -
Smoking - 0.09 -
Alcohol - 0.25 -
Normalised Wall Index Cocaine use - 0.38 -
Age 0.001 (20.003, 0.0) 0.05 20.001 (20.003, 0.0) 0.05
Gender - 0.6 -
BSA 20.05 (20.11, 0.001) 0.05 20.05 (20.10, 0.001) 0.06
Smoking - 0.68 -
Alcohol - 0.3 -
doi:10.1371/journal.pone.0089710.t003
Table 4. Cardiac mass, structure and function parameters.
Non users Users p value
LVEDV (ml) 170624 179632 0.35
LVEDV index (ml/m2) 88612 8665 0.7
LVESV (ml) 65612 68615 0.44
LVESV index (ml/m2) 3366 3268 0.8
LV Mass (g) 105616 124625 0.01
LV Mass index (g/m2) 5468 61614 0.04
LVEF (%) 6264 6264 0.94
LA size (cm) 3.560.3 3.860.6 0.04
LA size index (cm/m2) 1.860.2 1.860.2 0.76
PFR (ml/msec) 0.6160.17 0.5760.13 0.38
TPFR (msec)* 248.1676.3 307.96207 0.45
* indicates variable analysed by Mann-Whitney U test.
doi:10.1371/journal.pone.0089710.t004
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believed to be relatively harmless’’, and ‘‘have an image of
themselves as invincible’’ [27]. Significantly, it was from a similar
group that we witnessed a spate of individuals presenting with
large MIs [9]. One of the difficulties with recruiting via the
community and not via formal drug rehabilitation centres is the
reluctance of those who do not identify as having a formal clinical
addiction to volunteer for medical research. The resulting limited
number of participants, a potential weakness of the study, was
partially counteracted by the power provided by the precision of
CMR measurements allowing a detailed and precise anatomical
and functional cardiovascular assessment to be performed in a
single de-identified visit. For example in our study, the precision of
LV mass index measurement with CMR gives us an 88% power to
detect a 10% increase in this parameter.
Potential confounding effects related to the higher incidence of
smoking, alcohol and illicit drug use in the cocaine user group
need to be considered, particularly given the known association of
smoking with vascular stiffness and of alcohol with SBP. In our
study neither smoking nor alcohol had significant effects on SBP or
LVM, although smoking was a predictor of vascular stiffness. In all
cases, the relationship of cocaine use with SBP, LVM and vascular
stiffness remained significant after including smoking and alcohol
consumption in the analyses. We also performed secondary
analyses examining the impact of cocaine use on SBP, LVM
and arterial compliance after excluding smokers (Table S3 in File
S1). Aortic compliance remained significantly less in cocaine users
versus controls. The remaining parameters showed similar trends
to the primary analyses, but statistical power was limited due to
reduced numbers. In a separate secondary analysis we excluded
heavier drinkers (those who drank .10 standard drinks per week)
(Table S3 in File S1). SBP, LVM, and arterial compliance
differences trended in the same direction as the primary analyses,
but were not significant. Finally, we performed additional analyses
on a strategically matched control group, which further supported
initial data, supporting cocaine use as an important predictor of
SBP, LVM and vascular stiffness (Tables S4–6 in File S1).
The increase in SBP in cocaine users was present despite a 48-
hour period of abstinence, and was independent of age, BSA,
gender, alcohol and smoking history. Although cocaine ingestion
causes acute rapid and extreme increases in blood pressure via
mechanisms including potent sympathomimetic properties and
arterial vasoconstriction, the effects over the longer term are not
well understood. One possible mechanism for the persistence of
systolic hypertension in cocaine users observed in this study is an
effect of cocaine on arterial stiffness - a hypothesis that is supported
by our results. Cocaine users in our cohort had significant
decreases in compliance and distensibility, with reciprocal
increases in stiffness index and pulse wave velocity compared to
controls. This is similar to a report of altered aortic properties in
long-term crack cocaine abusers demonstrated by echocardiogra-
phy [28]. As in this study, our aortic stiffness parameters correlated
with duration and frequency of cocaine use. Such an association is
consistent with a cumulative effect of cocaine exposure on the
vessel wall. Interestingly, the lack of increased wall thickness in our
cocaine users suggests that the arterial stiffness effect of cocaine is
via alteration of the proportion of elastic versus non-elastic content
ratio, rather than vascular smooth muscle hypertrophy. It should
also be noted that arterial stiffness might be overestimated in this
study by using brachial pulse pressure measurements instead of
central [29].
A major finding of this study is that the cocaine users displayed
significantly greater LVMs than control subjects, and that cocaine
use was the most significant contributor to LVM in the statistical
model. The observation of increased LVM in cocaine users
supports and extends previous reports of this association in cohorts
with heavier reported use of cocaine [13,14]. The correlation of
duration and frequency of cocaine use with LVM also supports
this relationship. It should be noted, however, that all individual
LVM values of both groups fell into the normal range of values
according to age and gender [30]. To ensure we did not
underestimate LVM, we additionally indexed LVM to height to
the power of 2.7. This indexation method has been shown to offer
a more accurate estimation of LVM in overweight and obese
subjects [31]. However, using LVM indexed in this fashion did not
alter our findings thus has not been presented.
Despite the increased SBP, LVM and aortic stiffness, we did not
detect any differences in diastolic function in cocaine users. Non-
invasive quantitative assessment of diastolic function is mostly
performed with transthoracic echocardiography in clinical prac-
tice, however CMR has previously been validated and used to
evaluate LV relaxation and stiffness abnormalities using a
combination of left atrial size measurement, phase-contrast
evaluation of transmitral flow and LV filling (PFR and TPF)
[22]. We did observe an association of decreasing diastolic
function with age, supporting the use of the measured CMR
parameters, however it is possible that CMR does not provide the
sensitivity of echocardiography. Our study may also be under-
powered to detect these diastolic parameters. Indeed, cocaine use
Table 5. Statistical analyses of cardiac mass.
Dependent Variables Variables in Model Univariate B (95% CI) p value Multivariate B (95% CI) p value
LVM Cocaine use 18.9 g (5.5, 32.4) 0.007 21.8 g (9.3,34.4) 0.001
Age - 0.4 -
Gender 229.0 g (251.8, 26.2) 0.01 -
BSA 41.9 g (7.2, 76.6) 0.02 -
Smoking - 0.34 -
Alcohol - 0.2 -
LVM index Cocaine use 7.7 g.m-2 (0.5, 15.0) 0.04 7.71 g.m-2 (0.5,15.0) 0.038
Age - 0.47 -
Gender - 0.16 -
Smoking - 0.38 -
Alcohol 0.34 g.m-2 (20.02,0.69) 0.06 -
doi:10.1371/journal.pone.0089710.t005
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has previously been associated with diastolic dysfunction measured
by echocardiography, even in the absence of left ventricular
hypertrophy [14].
The lack of LGE evidence of silent MI or systolic dysfunction in
this study contrasts with previous reports in cocaine addicts
[11,12,32]. Indeed, in a recent study by Aquaro et al. [11], 47% of
subjects with a clinical diagnosis of cocaine addiction had
myocardial fibrosis demonstrated by LGE, with 32% of these
being in an ischaemic pattern. Differences in cohort characteristics
may explain at least part of this discrepancy, with Aquaro et al.
concluding that the results ‘‘may not be applicable to most
recreational (‘weekend’) cocaine users’’. Indeed, there was a much
higher reporting of intravenous administration of cocaine (33%
versus 5%) in their cohort; and the rate of clinically diagnosed
polydrug addiction was high at 53%. This latter figure is difficult
to compare to our study, which only identified ‘use’ of other illicit
substances, not ‘addiction’. Alcohol co-consumption appears to be
an important factor in the toxic effects of cocaine, potentially by
altered hepatic biotransformation of cocaine and the production of
the toxic metabolite cocaethylene, as well as inhibition of cocaine
clearance [33,34]. Interestingly, the lack of LGE present in our
cohort appears to contradict this proposed association given our
subjects reported drinking an average of 18 drinks per week.
The main limitation of this study - its sample size - has already
been discussed. In addition, as the subjects were completely
anonymous, and had only one study visit, we relied on self-
reporting in the study questionnaire for information on baseline
characteristics. The decision to use this approach was based on
previous work by members of our team, which found that self-
reported data on drug use patterns are sufficiently reliable and
valid [35,36]. Data on previous blood pressure measurements of
participants, particularly prior to the commencement of cocaine
use, or equivalent time period in the control group, would also
assist in interpreting the data. Designing a questionnaire to identify
the relative frequency of concomitant use of alcohol and cocaine
may also have been helpful to understand the mechanism of
cardiovascular toxicity given the theoretical pharmacological
interaction.
This is the first study to examine the cardiovascular effects of
cocaine use in ‘non-addict’ individuals who consider themselves
‘social’ users (with other studies focusing on addicts, recruited
through treatment centres). Although this group is thought to
represent a large majority of cocaine users in our community, the
illicit nature of cocaine use makes recruitment notoriously difficult.
CMR provided the power to study this group and compared with
the non-user control cohort, cocaine users had increased aortic
stiffness, an 8 mmHg higher SBP, and a 19 g greater left
ventricular mass. These measures are all well known risk factors
for premature cardiovascular events, highlighting the dangers of
cocaine use even in a ‘social’ setting.
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